David Cade

David Cade

Chief Tech/Sci/R&D Officer at TELIX PHARMACEUTICALS LIMITED

Net worth: 4 M $ as of 31/07/2026

57 year
Consumer Services
Health Technology
Commercial Services

Profile

David N.
Cade
is currently a Member at the Australian Institute of Co. Directors and Group Chief Medical Officer at Telix Pharmaceuticals Ltd. since 2024.
Formerly, Dr. Cade was Chief Medical Officer at Cochlear Ltd. and Chief Medical Officer at Sirtex Medical Pty Ltd. from 2012 to 2017.
Education includes an MBA from Melbourne Business School, a doctorate from Monash University, and an MBA from Escuela Superior de Administración y Dirección de Empresas.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
18/03/2026 373,133 ( 0.11% ) 4 M $ 31/07/2026

David Cade active positions

CompaniesPositionStart
TELIX PHARMACEUTICALS LIMITED Chief Tech/Sci/R&D Officer 01/01/2024
Corporate Officer/Principal -

Former positions of David Cade

CompaniesPositionEnd
SIRTEX MEDICAL LIMITED Chief Tech/Sci/R&D Officer 01/10/2017
COCHLEAR LIMITED Chief Tech/Sci/R&D Officer -
See the detail of David Cade's experience

Training of David Cade

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

63

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Consumer Services

Health Technology

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Health Technology